Chicken Intestine Microsomes

Details

Chicken Intestine Microsomes, derived from intestine tissue, are essential for studying oral drug first-pass metabolism and intestine enzyme functions. They provide a specialized platform for intestine metabolism research due to their rich CYP3A and UGT enzyme content, making them a key tool for predicting oral drug bioavailability.

Isolated via differential centrifugation and validated for enzyme activity by MileCell, these microsomes are available from multiple species including Rat, Mouse, Dog, Monkey, and others.

Features and Benefits

▪‌Quality Assurance. All batches undergo comprehensive quality control procedures to ensure product integrity and batch-to-batch consistency.

▪‌Comprehensive Characterization. Characterization of key CYP450 and Phase II enzyme activities, ensuring exceptional metabolic performance and specificity for consistent and reliable results.

▪Scalable Production. Large lots derived from donor pools of intestine subcellular fractions to minimize lot-to-lot variation and ensure long-term availability across experimental replicates.

▪Available intestine preparations format: PMSF-containing‌ and PMSF-free.

▪Well-Stocked, Fresh & Viable Inventory‌. Customizable: Gender, Species, Vial Size, Batch Size, etc.

Quality

This product is intended for in-vitro research and manufacturing applications only. All biological samples supplied by MileCell, as well as any materials derived from them, are strictly for in-vitro research use. They are not approved or intended for use as source material in clinical therapies.

Microsomes are provided as a suspension at a concentration of 20 mg/mL in a 250 mM sucrose buffer. Each vial contains a total volume of 0.5 mL and 0.15 mL. Every production lot is tested for enzymatic activity and metabolic stability to ensure consistent performance.